NEW YORK (Reuters Health) – Patients with type 2 diabetes who have fairly high cholesterol levels despite simvastatin treatment do better with the addition of ezetimibe, Italian investigators…
NEW YORK (Reuters Health) – Episodes of dyspnea are more common in patients treated with the antiplatelet agent than in those taking clopidogrel, although the clinical importance of…
NEW YORK (Reuters Health) – Patients with chronic kidney disease not requiring hemodialysis present a dilemma when it comes to treating concomitant multivessel coronary artery disease (CAD): coronary…
NEW YORK (Reuters Health) – Elderly men with limitations in mobility who are treated with testosterone to improve strength appear to be at increased risk of cardiovascular-related adverse…
NEW YORK (Reuters Health) – Statins may be overused in patients without cardiovascular disease, according to a report in Archives of Internal Medicine. The researchers pooled data from…
NEW YORK (Reuters Health) – Two reports today in two separate journals — a meta-analysis and a large retrospective study — provide more evidence linking the thiazolidinedione rosiglitazone…
NEW YORK (Reuters Health) – Patients taking clopidogrel because of their high risk for cardiovascular events are more likely to have a major event if they carry the…
NEW YORK (Reuters Health) – While some patients with acute coronary syndrome (ACS) and elevate natriuretic peptide levels can benefit from treatment with various suppressors of the renin-angiotensin-aldosterone…
NEW YORK (Reuters Health) – For patients with diabetes and hypertension, an antihypertensive regimen combining an ACE inhibitor with a calcium channel blocker provides better protection against cardiovascular…
NEW YORK (Reuters Health) – Even though carotid intima media thickness (cIMT) independently predicts cardiovascular disease events, this parameter does not add useful information to traditional risk factor…